Pulmatrix, Inc. (PULM)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenues | - | - | 366 | 1,552 |
| Loss on disposal group held for sale | - | - | - | 2,618 |
| Research and development | 14 | 19 | 814 | 2,834 |
| General and administrative | 1,534 | 1,828 | 2,209 | 2,001 |
| Loss on mannkind transaction | - | - | - | - |
| Total operating expenses | 1,548 | 1,847 | 3,023 | 7,453 |
| Loss from operations | -1,548 | -1,847 | -2,657 | -5,901 |
| Interest income | - | 53 | 101 | 133 |
| Other expense, net | -43 | -80 | -31 | -43 |
| Interest income | 41 | - | - | - |
| Fair value adjustment of warrants | -1 | -66 | - | - |
| Total other income (expense), net | -1 | 39 | 70 | 90 |
| Net loss | -1,549 | -1,808 | -2,587 | -5,811 |
| Net loss per share attributable to common stockholders basic | -0.42 | 0.5 | -0.71 | -1.59 |
| Net loss per share attributable to common stockholders diluted | -0.42 | 0.5 | -0.71 | -1.59 |
| Weighted average common shares outstanding basic | 3,652,285 | 3,652,285 | 3,652,285 | 3,652,285 |
| Weighted average common shares outstanding diluted | 3,652,285 | 3,652,285 | 3,652,285 | 3,652,285 |